NEW YORK, July 6, 2022 /PRNewswire/ — Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:
- Epizyme, Inc. (NASDAQ: EPZM)
Epizyme has agreed to merge with Ipsen. Under the proposed transaction, Epizyme shareholders will receive $1.45 in cash per share plus one contingent value right per share.
- Radius Health, Inc. (NASDAQ: RDUS)
Radius has agreed to merge with Gurnet Point Capital and Patient Square Capital. Under the proposed transaction, Radius shareholders will receive $10.00 per share in cash plus a contingent value right of $1.00 per share payable upon TYMLOS® net sales reaching 300 million.
- Ocean Bio-Chem, Inc. (NASDAQ: OBCI)
Ocean Bio-Chem has agreed to merge with OneWater. Under the proposed transaction, Ocean Bio-Chem shareholders will receive $13.08 in cash per share.
- Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
Convey agreed to merge with TPG. Under the proposed transaction, Convey shareholders will receive $10.50 in cash per share.
Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.
Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq. by email at [email protected] or telephone at (212) 709-8245. The consultation and case are free with no obligation to you. Moore Kuehn pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Moore Kuehn is a 5-star client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please visit http://www.moorekuehn.com/practice/new-york-securities-litigation/.
Attorney advertising. Prior results do not guarantee similar outcomes.
Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
View original content to download multimedia:https://www.prnewswire.com/news-releases/moore-kuehn-encourages-epzm-rdus-obci-and-cnvy-investors-to-contact-law-firm-301581774.html
SOURCE Moore Kuehn, PLLC